Discover
IMNM
Immunome, Inc.
23.97
1 x 23.65
2 x 31.10
bid
ask
+
0.04
0.17%
2 @ 07:30 PM
24.16 +0.19 (0.81%)
| Ytd | 11.59% | |
| 1y | 143.35% |
23.36
day range
24.24
9.39
52 week range
29.83
| Open | 24.01 | Prev Close | 23.93 | Low | 23.36 | High | 24.24 | Mkt Cap | 2.72B |
| Vol | 3.96M | Avg Vol | 1.26M | EPS | -2.53 | P/E | N/A | Forward P/E | -9.67 |
| Beta | 2.13 | Short Ratio | 13.13 | Inst. Own | 106.77% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 25.27 | 200-d Avg | 22.59 | 1yr Est | 36.31 |
| Income Statement | |||
| Operating Expenses | 78.14M | ||
| Research and Development Expense | 59.89M | ||
| Selling, General and Administrative Expense | 18.25M | ||
| Operating Income | -78.14M | ||
| Net Income | -73.13M | ||
| Net Income Common Stock | -73.13M | ||
| Net Income Common Stock (USD) | -73.13M | ||
| Consolidated Income | -73.13M | ||
| Earnings per Basic Share | -0.65 | ||
| Earnings per Basic Share (USD) | -0.65 | ||
| Earnings per Diluted Share | -0.65 | ||
| Earning Before Interest & Taxes (EBIT) | -73.13M | ||
| Earning Before Interest & Taxes (USD) | -73.13M | ||
| Weighted Average Shares | 113.27M | ||
| Weighted Average Shares Diluted | 113.27M | ||
| Balance Sheet | |||
| Cash and Equivalents | 217.92M | ||
| Cash and Equivalents (USD) | 217.92M | ||
| Investments | 302.29M | ||
| Investments Current | 302.29M | ||
| Current Assets | 538.45M | ||
| Property, Plant & Equipment Net | 21.30M | ||
| Total Assets | 565.38M | ||
| Total Debt | 4.59M | ||
| Current Liabilities | 35.71M | ||
| Debt Non-Current | 4.59M | ||
| Total Liabilities | 40.30M | ||
| Accumulated Retained Earnings (Deficit) | -855.13M | ||
| Accumulated Other Comprehensive Income | -333.00K | ||
| Shareholders Equity | 525.08M | ||
| Shareholders Equity (USD) | 525.08M | ||
| Assets Non-Current | 26.94M | ||
| Total Debt (USD) | 4.59M | ||
| Liabilities Non-Current | 4.59M | ||
| Trade and Non-Trade Payables | 6.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.16M | ||
| Net Cash Flow from Financing | 1.06M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -364.99M | ||
| Capital Expenditure | -2.18M | ||
| Issuance (Purchase) of Equity Shares | 1.06M | ||
| Net Cash Flow from Investing | -304.35M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -302.18M | ||
| Net Cash Flow from Operations | -61.69M | ||
| Share Based Compensation | 8.80M | ||